Globalpharma

A wholly owned subsidiary of Dubai Investments, Globalpharma, is a leading generics partner in the region, manufacturing and marketing pharmaceutical products in more than 14 countries across the GCC, Middle East, and neighboring markets.

Globalpharma manufactures and distributes generic pharmaceutical products in almost all lifestyle disease segments, including Cardiovasculars, Anti- ulcerants, Anti-Diabetics, Anti-Arthritis, Analgesics including NSAIDs (Nonsteroidal anti-inflammatory drugs), Respiratory, Anti-histamine formulations, Anti- infectives and Mulitvitamin supplements.